Pier Paolo Olimpieri
9PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Oct 28, 2025
Vitamin K Antagonists (VKAs) and Novel Oral Anticoagulants (NOACs) Safety Comparison Based on Data from EudraVigilance Database.Pier Paolo Olimpieri, Fanny Erika Palumbo, Gaetano Giuffrida
|Oct 04, 2024
The impact of starting dose on overall survival in myelofibrosis patients treated with ruxolitinib: A prospective real-world study on AIFA monitoring registries.Massimo Breccia, Simone Celant, Francesca Palandri
|Oct 18, 2023
Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries.Marcello Arca, Simone Celant, Pier Paolo Olimpieri
|Jun 28, 2023
Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency.Gian Matteo Rigolin, Pier Paolo Olimpieri, Valentina Summa
|Jul 29, 2022
Management of chronic myeloid leukaemia patients treated with ponatinib in a real-life setting: A retrospective analysis from the monitoring registries of the Italian Medicines Agency (AIFA).Massimo Breccia, Pier Paolo Olimpieri, Simone Celant
|Jun 24, 2022
Mortality in SARS-CoV-2 Hospitalized Patients Treated with Remdesivir: A Nationwide, Registry-Based Study in Italy.Pierluigi Russo, Evelina Tacconelli, Pier Paolo Olimpieri
Pageof 2
Frequent Collaborators
3 joint publications
Massimo Breccia
2 joint publications
Luca Tomassini
2 joint publications
Paolo Corradini
1 joint publications
Alessandra Iurlo
1 joint publications
Alexandre M J J Bonvin
1 joint publications
Lydia Scarfò
1 joint publications
Mariarosaria Sessa
1 joint publications
Paolo Ghia
1 joint publications
Marcello Arca
1 joint publications
Simone Celant
